Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures
Clinical trial NCT03355300 · TERMINATED
Trial details
- NCT number
- NCT03355300
- Sponsor
- Radius Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-20
- Primary completion
- 2019-06-24
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.